PMDA drug package insert
破トキ「ビケンF」
PMDA Prescription drug · 一般財団法人阪大微生物病研究会 · package insert Dec 1, 2025
Key facts
| Brand names | 破トキ「ビケンF」 |
|---|---|
| Nonproprietary names | 沈降破傷風トキソイド |
| Companies | 製造販売元／一般財団法人阪大微生物病研究会, 販売元／田辺ファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | トキソイド類 |
| Therapeutic category codes | 876322 |
| YJ codes | 6322400X2099 |
| Approval numbers | 21800AMZ10377000 |
| Package insert edition | 第3版 |
| Package insert date | Dec 1, 2025 |
| PMDA document key | 630144_6322400X2099_1 |
| PMDA company code | 630144 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- 1–9 Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: